W
Waystar Holding Corp. Common Stock (WAY)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
$28.11
+0.12 (+0.43%)
Market Cap: $5.39B
Last updated: Nov 17, 2026 at 11:05 AM ET
Waystar Holding Corp. Common Stock (WAY) P/E Ratio & Valuation Multiples
Waystar Holding Corp. Common Stock (WAY) trades at 18.9x trailing earnings and 4.3x sales. Its forward P/E is 14.4x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 31.2% higher over the next year. Its free cash flow yield is 4.9%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 18.9x |
| Forward P/E | 14.4x |
| Price to sales | 4.3x |
| Price to book | 1.3x |
| EV/EBITDA | 15.4x |
| Price to FCF | 20.4x |
|---|---|
| EV/FCF | 25.9x |
| PEG | N/A |
| FCF yield | 4.9% |
As of Nov 17, 2026
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About WAY
What is WAY's forward P/E ratio?
Waystar Holding Corp. Common Stock has a forward P/E ratio of 14.4x.
Is WAY stock overvalued?
GNG's valuation label for WAY is Undervalued.
What is WAY's price to sales ratio?
Waystar Holding Corp. Common Stock has a price to sales ratio of 4.3x.
WAY pages: Overview, Earnings, Forecast, Financials, Valuation